Tokyo

London

New York

Register

Sign In

EUR/USD

1.1664

0.0036

0.31%

GBP/USD

1.2995

0.0029

0.23%

USD/JPY

111.13

-0.7425

-0.66%

USD/CHF

0.9459

-0.0056

-0.59%

EUR/GBP

0.8976

0.0008

0.08%

USD/CAD

1.2542

-0.0054

-0.43%

NZD/USD

0.7455

0.0052

0.71%

EUR/JPY

129.61

-0.4680

-0.36%

EUR/CHF

1.1033

-0.0031

-0.28%

CymaBay Therapeutics Inc

NASDAQ: CBAYHealthcare / Biotechnology / USA
7.75+0.45+6.16%Vol 2 628 9391Y Perf 364.07%
Jul 21st, 2017 16:00
BID7.71 ASK7.77
Open7.30 Previous Close7.30
Pre-Market7.30 After-Trading7.86
 - -%  0.11 1.42%
Target Price
7.17 
Analyst Rating
Strong Buy 1.00
Potencial %
-7.48 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)210 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
97.20 
Earnings Date
8th Aug 2017

Today's Price Range

7.167.94

 

52wk Range

1.157.94

Summary:

Strong Buy

Technical Indicators: Strong Buy
Moving Averages: Strong Buy
Performance
1 Month
43.42%
3 Months
92.61%
6 Months
324.42%
1 Year
364.07%
3 Years
28.30%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CBAY7.750.45006.16
AAPL150.27-0.0700-0.05
GOOG972.924.77000.49
MSFT73.79-0.4300-0.58
XOM80.12-0.7400-0.92
WFC54.17-0.7100-1.29
JNJ135.31-1.2600-0.92
FB164.43-0.1000-0.06
GE25.91-0.7800-2.92
JPM90.89-0.3100-0.34
...

TickerPriceChg.%52 Week High
CTAS138.439.19139.39
COF87.948.5596.92
ETFC41.635.1341.83
SYF30.874.5438.06
MCO132.574.25133.62
FITB26.182.7128.97
NFLX188.542.69191.50
KMX66.092.6669.11
VRTX163.172.41167.00
AAP105.271.98177.83
CCI99.171.95104.68
DFS62.531.8974.33
AEP69.981.8672.97
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.30
Long Term Debt to Total Capital 0.37
Total Debt to Equity 0.88
Interest Coverage -18.20
Leverage Ratio 3.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-105.30
EBITDA Margin-105.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 17.61
PS Ratios 33.89
Price to Cash Flow -
Price to Free Cash Flow -12.20
Cash Flow Per Share -0.80
Price to Tangible Book17.61
Book Value per Share0.32
Enterprise Value (in ths.)147 214
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-48.03
ROE last 12 Months -169.63
Return on Assets (5Y Avg) 66.52
ROA last 12 Months -84.19
Return on Capital (5Y Avg) -
ROC last 12 Months -98.76
Return on invested Capital Q -33.75
Return on invested Capital Y-101.72
Assets Turnover0.10
Receivables Turnover52.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)4 793
Revenue per Share 0.17
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.27-0.2025.93
Q04 2016-0.30-0.300.00
Q03 2016-0.31-0.2519.35
Q02 2016-0.32-0.306.25
Q01 2016-0.28-0.29-3.57
Q04 2015-0.35-0.2625.71
Q03 2015-0.35-0.2722.86
Q02 2015-0.42-0.0978.57
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.257.41Positive
9/2017 QR-0.14-7.69Negative
12/2017 FY-0.6919.77Positive
12/2018 FY-0.5840.82Positive
Next Report Date8th Aug 2017
Estimated EPS Next Report-0.25
Estimates Count4
EPS Growth Next 5 Years %0.00
Volume Overview
Volume2 628 939
Shares Outstanding (in ths.)28 750
Trades Count7 950
Dollar Volume19 149 093
Avg. Volume686 076
Avg. Weekly Volume6 398 015
Avg. Monthly Volume1 923 169
Avg. Quarterly Volume843 176

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

82%18%

Bearish Bullish

78%22%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
2 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

Plus500
x